Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology is a research paper published in Journal of Biological Chemistry (2020). On theSindex it has a DataRank of 0.691. It has been cited 19 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.242
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
Vetenskapsrådet
Grant: 521-2014-3341
Cancerfonden
Grant: 150393 CAN 2014/702
Worldwide Cancer Research
Grant: 130086
Barncancerfonden
Grant: TJ-2014-0038
Barncancerfonden
Grant: PR-2014-0038
Leukemia and Lymphoma Society
Grant: 6137-14
HHS | National Institutes of Health
Grant: R01 CA95684
Vetenskapsrådet
Grant: 538-2013-8807
NCI NIH HHS
Grant: R01 CA095684
NCI NIH HHS
Grant: R01 CA248794
Swedish Research Council
Grant: unidentified
unidentified
National Institutes of Health
Grant: 2R01CA095684-05
Resistance of CML Stem Cells to Imatinib (Gleevec)
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals